Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cel-Sci Corporation Common Stock (NY:CVM)

4.350 +0.390 (+9.85%)
Streaming Delayed Price Updated: 3:24 PM EDT, Jul 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 556,316
Open 4.050
Bid (Size) 4.310 (3)
Ask (Size) 4.390 (2)
Prev. Close 3.960
Today's Range 3.950 - 4.390
52wk Range 1.980 - 66.60
Shares Outstanding 91,037,256
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules
From CEL-SCI Corporation
Via Business Wire
Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga

Performance

YTD
-65.1%
-65.1%
1 Month
+70.6%
+70.6%
3 Month
-44.5%
-44.5%
6 Month
-63.2%
-63.2%
1 Year
-89.7%
-89.7%

More News

Read More
Why Datavault AI Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Topics Artificial Intelligence
Which stocks are moving on Friday?
Via Chartmill
CEL-SCI Stock Soars On Imminent Partnership With Saudi Arabian Pharma Company For Cancer Drug: Retail’s Thrilled
Via Stocktwits
CEL-SCI Announces Pricing of $5.7 Million Offering Priced At-the-Market Under NYSE American Rules
From CEL-SCI Corporation
Via Business Wire
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
CEL-SCI to Sign Partnership Agreement With Leading Saudi Arabian Pharma Company for Multikine in the Treatment of Head & Neck Cancer
From CEL-SCI Corporation
Via Business Wire
CEL-SCI Announces Closing of Public Offering
From CEL-SCI Corporation
Via Business Wire
FDA’s Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients
From CEL-SCI Corporation
Via Business Wire
Keep an eye on the top gainers and losers in Thursday's session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
These stocks are moving in today's session
Via Chartmill
Dow Moves Higher; US Initial Jobless Claims Fall
Via Benzinga
Topics Stocks
Which stocks are gapping on Thursday?
Via Chartmill
Nasdaq Gains Over 100 Points; BJ's Wholesale Earnings Top Views
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Urban Outfitters Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
CEL-SCI Announces Pricing of Public Offering
From CEL-SCI Corporation
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
CEL-SCI Announces Proposed Public Offering
From CEL-SCI Corporation
Via Business Wire
CEL-SCI’s Multikine Investigational Cancer Medicine Potentially Available for Commercialization by Summer 2025 in Saudi Arabia
From CEL-SCI Corporation
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is Cel-Sci Corporation Common Stock publicly traded?
Yes, Cel-Sci Corporation Common Stock is publicly traded.
What exchange does Cel-Sci Corporation Common Stock trade on?
Cel-Sci Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Cel-Sci Corporation Common Stock?
The ticker symbol for Cel-Sci Corporation Common Stock is CVM on the New York Stock Exchange
What is the current price of Cel-Sci Corporation Common Stock?
The current price of Cel-Sci Corporation Common Stock is 4.350
When was Cel-Sci Corporation Common Stock last traded?
The last trade of Cel-Sci Corporation Common Stock was at 07/21/25 03:24 PM ET
What is the market capitalization of Cel-Sci Corporation Common Stock?
The market capitalization of Cel-Sci Corporation Common Stock is 396.01M
How many shares of Cel-Sci Corporation Common Stock are outstanding?
Cel-Sci Corporation Common Stock has 396M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.